Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease.

F H Durie, A Aruffo, J Ledbetter, K M Crassi, W R Green, L D Fast, R J Noelle

Open source

DOI
10.1172/jci117453
Published
1994-09-01
Container
Journal of Clinical Investigation
Publisher
American Society for Clinical Investigation
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1172/jci117453,
  title = {Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease.},
  author = {F H Durie and A Aruffo and J Ledbetter and K M Crassi and W R Green and L D Fast and R J Noelle},
  year = {1994},
  journal = {Journal of Clinical Investigation},
  doi = {10.1172/jci117453},
  url = {https://doi.org/10.1172/jci117453}
}

RIS

TY  - JOUR
TI  - Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease.
AU  - F H Durie
AU  - A Aruffo
AU  - J Ledbetter
AU  - K M Crassi
AU  - W R Green
AU  - L D Fast
AU  - R J Noelle
PY  - 1994
JO  - Journal of Clinical Investigation
DO  - 10.1172/jci117453
UR  - https://doi.org/10.1172/jci117453
ER  - 

APA

Durie, F. H., Aruffo, A., Ledbetter, J., Crassi, K. M., Green, W. R., Fast, L. D., & Noelle, R. J. (1994). Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease.. Journal of Clinical Investigation. https://doi.org/10.1172/jci117453

Source records